226 related articles for article (PubMed ID: 24670424)
1. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
[TBL] [Abstract][Full Text] [Related]
2. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
3. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
Watanabe T; Asano N; Murray PJ; Ozato K; Tailor P; Fuss IJ; Kitani A; Strober W
J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
[TBL] [Abstract][Full Text] [Related]
4. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
5. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
[TBL] [Abstract][Full Text] [Related]
6. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
[TBL] [Abstract][Full Text] [Related]
7. The NOD2-RICK complex signals from the plasma membrane.
Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease.
Dionne S; Calderon MR; White JH; Memari B; Elimrani I; Adelson B; Piccirillo C; Seidman EG
Mucosal Immunol; 2014 Nov; 7(6):1405-15. PubMed ID: 24781050
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of NOD2 susceptibility mutations in Crohn's disease.
Strober W; Kitani A; Fuss I; Asano N; Watanabe T
Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S5-9. PubMed ID: 19079230
[TBL] [Abstract][Full Text] [Related]
11. Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression.
Masuta Y; Minaga K; Kurimoto M; Sekai I; Hara A; Omaru N; Okai N; Otsuka Y; Takada R; Yoshikawa T; Masaki S; Kamata K; Honjo H; Arai Y; Yamashita K; Kudo M; Watanabe T
Int Immunol; 2023 Feb; 35(2):79-94. PubMed ID: 36171063
[TBL] [Abstract][Full Text] [Related]
12. ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses.
Honjo H; Watanabe T; Arai Y; Kamata K; Minaga K; Komeda Y; Yamashita K; Kudo M
Int Immunol; 2021 Jan; 33(2):91-105. PubMed ID: 32909611
[TBL] [Abstract][Full Text] [Related]
13. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
14. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
15. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
[TBL] [Abstract][Full Text] [Related]
16. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
[TBL] [Abstract][Full Text] [Related]
17. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
Yan R; Liu Z
Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
19. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
